Related Experiment Video

Updated: Aug 8, 2026

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles
09:00

An In Vitro Enzymatic Assay to Measure Transcription Inhibition by Gallium(III) and H3 5,10,15-tris(pentafluorophenyl)corroles

Published on: March 18, 2015

Taurolidine inhibits tumor cell growth in vitro and in vivo

M McCourt1, J H Wang, S Sookhai

  • 1Department of Surgery, Cork University Hospital, Ireland.

Annals of Surgical Oncology
|October 18, 2000
PubMed
Abstract

Insights

Taurolidine significantly reduced colorectal tumor cell growth and peritoneal metastasis in rats. This study highlights Taurolidine

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Taurolidine, a taurine derivative, possesses antiendotoxin, antibacterial, and antiadherence properties.
  • Investigated potential anti-tumor effects of Taurolidine on colorectal cancer.

Purpose of the Study:

  • To evaluate the efficacy of Taurolidine in inhibiting colorectal tumor cell growth.
  • To assess Taurolidine's impact on tumor development in vitro and in vivo.

Main Methods:

  • In vitro: DHD/K12/TRb cells treated with varying Taurolidine concentrations (5-25 µg/ml). Assessed proliferation, viability, death, and apoptosis.
  • In vivo: BD IX rats with induced peritoneal metastases treated with Taurolidine (100 mg/kg) or PBS. Tumor burden quantified after 24 days.

Main Results:

  • In vitro: Taurolidine (25 µg/ml) decreased proliferation by 4-fold and increased necrosis by 4-fold, showing dose-dependent viability reduction.
  • In vivo: Taurolidine administration significantly reduced tumor nodules (3 vs. 649).

Conclusions:

  • Taurolidine effectively inhibits colorectal tumor cell growth in vitro and reduces peritoneal metastasis in vivo.
  • Taurolidine demonstrates potential for preventing peritoneal metastases in colorectal cancer.

More Related Videos

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.